Glucovision (Citrate) (2020-05-11)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Radiopharmaceuticals
Issue: Product Safety
Audience: Healthcare Professionals, Hospitals, General Public
Department: Health Canada
Hazard classification: Type III
Glucovision (Citrate) 453 GBq/vial
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| T-200511FDG-1 | - Recalling Firm
- Centre for Probe Development and Commercialization (CPDC)
- 1280 Main St. W. NRB-A316
- Hamilton
- L8S 4K1
- Ontario
- CANADA
- Marketing Authorization Holder
- Centre for Probe Development and Commercialization (CPDC)
- 1280 Main St. W. NRB-A316
- Hamilton
- L8S 4K1
- Ontario
- CANADA
| Glucovision (Citrate) 453 GBq/vial | DIN 02328771 | Solution | Fludeoxyglucose 18F 453 GBq/vial |
Affected lot contains ethanol levels outside of the labelled claim.
Healthcare establishments